Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

被引：0
作者：
Gary T. Ferguson
Patrick Darken
Shaila Ballal
Mohd Kashif Siddiqui
Barinder Singh
Sumeet Attri
Ulf Holmgren
Enrico de Nigris
机构：
[1] Pulmonary Research Institute of Southeast Michigan,
[2] AstraZeneca,undefined
[3] Parexel International,undefined
[4] AstraZeneca,undefined
[5] AstraZeneca,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Chronic obstructive pulmonary disease; Exacerbations; Inhaled corticosteroid; Long-acting muscarinic antagonist; Long-acting β; -agonist; Lung function; Network meta-analysis; Patient-reported outcomes; Triple therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2956 / 2975
页数：19
相关论文
共 142 条
  • [31] Calzetta L(2015)Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? J Aerosol Med Pulmon Drug Deliv 28 219-496
  • [32] Matera MG(2017)Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners Respir Med 124 6-911
  • [33] Calzetta L(2019)Optimizing drug delivery in COPD: the role of inhaler devices Int J Chron Obstruct Pulmon Dis 14 343-464
  • [34] Cazzola M(2011)Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population J Med Econ 14 486-546
  • [35] Matera MG(2002)Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers Am J Manag Care 8 902-undefined
  • [36] Rogliani P(2015)Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers Ann Intern Med 163 461-undefined
  • [37] Zayed Y(2019)Good publication practice for communicating company-sponsored medical research: GPP3 Int J Chron Obstruct Pulmon Dis 14 531-undefined
  • [38] Barbarawi M(undefined)Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA undefined undefined undefined-undefined
  • [39] Kheiri B(undefined)undefined undefined undefined undefined-undefined
  • [40] Owen RK(undefined)undefined undefined undefined undefined-undefined
12345678910